The top 10 adverse events reported to the FDA FAERS database for ACE Inhibitors (Plain) are Angioedema, Acute kidney injury, Cough, Dyspnoea, Hypotension, Drug hypersensitivity, Dizziness, Hyperkalaemia, Drug ineffective, and Drug interaction. The distribution of these adverse events among the drugs marketed in this drug group are shown in the graph below. The Proportional Reporting Ratio (PRR) of these adverse events among ACE Inhibitor (Plain) drugs are also included to analyze the disproportional ratio. The data used in the calculation includes all adverse event reports submitted to FAERS for the ACE Inhibitors (Plain) from 2004 Q1 to 2024 Q3. Further analysis is required to confirm the potential signal for any of these drug-adverse events.
top of page
bottom of page
Comments